Stepan Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Stepan has a total shareholder equity of $1.2B and total debt of $688.5M, which brings its debt-to-equity ratio to 56.5%. Its total assets and total liabilities are $2.4B and $1.2B respectively. Stepan's EBIT is $72.5M making its interest coverage ratio 6.6. It has cash and short-term investments of $147.3M.

Belangrijke informatie

56.5%

Verhouding schuld/eigen vermogen

US$688.50m

Schuld

Rente dekkingsratio6.6x
ContantUS$147.30m
AandelenUS$1.22b
Totaal verplichtingenUS$1.19b
Totaal activaUS$2.41b

Recente financiële gezondheidsupdates

Recent updates

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

Nov 02
Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

Stepan Company: Not A Great Performance, But Good Value

Oct 30

Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

Aug 30
Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Aug 17
Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Stepan Company Is Making Great Progress

Jul 28

When Should You Buy Stepan Company (NYSE:SCL)?

Jul 24
When Should You Buy Stepan Company (NYSE:SCL)?

There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital

May 29
There Are Reasons To Feel Uneasy About Stepan's (NYSE:SCL) Returns On Capital

Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Apr 05
Stepan Company's (NYSE:SCL) Price In Tune With Earnings

Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Mar 22
Is There Now An Opportunity In Stepan Company (NYSE:SCL)?

Is Stepan (NYSE:SCL) Using Too Much Debt?

Feb 18
Is Stepan (NYSE:SCL) Using Too Much Debt?

Stepan Company: It's Wise To Remain Cautious

Feb 17

With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Jan 04
With Stepan Company (NYSE:SCL) It Looks Like You'll Get What You Pay For

Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Dec 17
Capital Allocation Trends At Stepan (NYSE:SCL) Aren't Ideal

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Dec 05
Are Investors Undervaluing Stepan Company (NYSE:SCL) By 27%?

Stepan Company: An Unfortunate Development Resulting In An Upside

Dec 03

When Should You Buy Stepan Company (NYSE:SCL)?

Oct 16
When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company: Don't Try To Catch The Falling Knife, Still Potentially Overvalued

Sep 17

Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Aug 31
Stepan (NYSE:SCL) Has A Somewhat Strained Balance Sheet

Stepan's Shares Are Reaching Even More Appealing Prices

Aug 28

Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Jul 18
Are Investors Undervaluing Stepan Company (NYSE:SCL) By 31%?

Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Jul 06
Investors Could Be Concerned With Stepan's (NYSE:SCL) Returns On Capital

Stepan Company: A Downward Revision Is Warranted

Jun 09

Is Stepan (NYSE:SCL) Using Too Much Debt?

May 23
Is Stepan (NYSE:SCL) Using Too Much Debt?

At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

May 01
At US$92.20, Is Stepan Company (NYSE:SCL) Worth Looking At Closely?

Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Mar 25
Stepan (NYSE:SCL) Ticks All The Boxes When It Comes To Earnings Growth

Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Mar 08
Returns On Capital At Stepan (NYSE:SCL) Have Stalled

Stepan Q4 2022 Earnings Preview

Feb 15

Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Feb 02
Here's Why Stepan (NYSE:SCL) Can Manage Its Debt Responsibly

Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Jan 05
Stepan Company (NYSE:SCL) Shares Could Be 30% Below Their Intrinsic Value Estimate

Stepan Company: Expect Outperformance To Continue

Jan 03

Analyse van de financiële positie

Kortlopende schulden: SCL's short term assets ($918.2M) exceed its short term liabilities ($721.3M).

Langlopende schulden: SCL's short term assets ($918.2M) exceed its long term liabilities ($473.1M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: SCL's net debt to equity ratio (44.4%) is considered high.

Schuld verminderen: SCL's debt to equity ratio has increased from 27.1% to 56.5% over the past 5 years.

Schuldendekking: SCL's debt is well covered by operating cash flow (30.5%).

Rentedekking: SCL's interest payments on its debt are well covered by EBIT (6.6x coverage).


Balans


Ontdek gezonde bedrijven